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Peripheral interactions between nociceptive fibers and mast cells
contribute to inflammatory pain, but little is known about mecha-
nisms mediating neuro-immune communication. Here we show that
metalloproteinase MT5-MMP (MMP-24) is an essential mediator of
peripheral thermal nociception and inflammatory hyperalgesia. We
report that MT5-MMP is expressed by CGRP-containing peptidergic
nociceptors in dorsal root ganglia and that Mmp24-deficient mice
display enhanced sensitivity to noxious thermal stimuli under basal
conditions. Consistently, mutant peptidergic sensory neurons hyper-
innervate the skin, a phenotype that correlates with changes in the
regulated cleavage of the cell-cell adhesion molecule N-cadherin. In
contrast to basal nociception, Mmp24/ mice do not develop ther-
mal hyperalgesia during inflammation, a phenotype that appears
associated with alterations in N-cadherin-mediated cell-cell interac-
tions between mast cells and sensory fibers. Collectively, our findings
demonstrate an essential role of MT5-MMP in the development of
dermal neuro-immune synapses and suggest that this metal-
loproteinase may be a target for pain control.
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Sensory neurons that innervate the skin are the primarymediators in the perception of external noxious and non
noxious stimuli. Under physiological conditions, sensory neu-
rons known as nociceptors are activated by acute painful stimuli
and, in situations of nerve damage or inflammation, sensitization
of primary sensory neurons leads to persistent neurogenic or
inflammatory pain, respectively (1, 2). It is becoming increas-
ingly clear that nociceptive processing in these pain states
requires the contribution of glial and immune cells (3). There-
fore, the elucidation of signaling relationships between nocicep-
tive primary afferents and peripheral immune cells appears
necessary to understand pain physiology and to develop thera-
peutic strategies for pain control.
Proteolytic remodeling of the extracellular matrix (ECM) is an
essential event in the development of both peripheral and central
nervous systems (4). MMPs (matrix metalloproteinases) and
ADAMs (a disintegrin andmetalloproteinase) have the ability to
cleave all major ECM protein components under physiological
conditions (4, 5). A concerted action of different proteases may,
therefore, be highly relevant to the construction and physiology
of neural circuits (6, 7). Numerous studies have implicated
ADAMs in the formation of neural connections in the devel-
oping nervous system (8–11). In contrast, the potential role of
MMPs in axonal elongation and guidance through regulated
cleavage of ligands and/or receptors involved in axon navigation
has been more elusive (7, 11–13).
MT5-MMP (Mmp24) is mainly expressed in neuronal cells of
both central and peripheral nervous systems, although its pres-
ence has also been detected in inflammatory cells (14–18).
MT5-MMP can degrade several ECM components, such as
inhibitory chondroitin sulfate proteoglycans, thereby promoting
neurite outgrowth in vitro (16, 19). Moreover, it appears capable
of mediating the cleavage of cell-adhesion molecule N-cadherin
in heterologous cells (20). On this basis, together with the
absence of A-fiber sprouting after sciatic nerve injury in a
mouse strain lacking MT5-MMP, it has been suggested that this
metalloproteinase may contribute to the ECM degradation
associated with neuronal plasticity (21). However, at present,
very little information is available about the in vivo functional
relevance ofMT5-MMP. In this work, we have generated mutant
mice deficient in MT5-MMP (Mmp24/) to further character-
ize the in vivo role of this protease in both physiological and
pathological processes.
Results
Generation of Mmp24-Deficient Mice. To analyze the in vivo role of
MT5-MMP, we generated mice with a targeted disruption in the
Mmp24 gene by replacing a 6-kb fragment containing exons 5–7
of Mmp24 with an antisense-oriented PGK-neo cassette (Fig.
1A). This deletion results in a loss of the catalytic domain and
part of the hemopexin domain of the protein. Chimeric founder
mice derived from two independent ES cell lines were mated to
C57BL/6J mice to generate heterozygous mice that were iden-
tified by Southern blot analysis. After intercrossing heterozygous
mice from the F1 generation, we obtained Mmp24/,
Mmp24/, and Mmp24/ mice (Fig. 1B) in the expected
Mendelian ratios. Northern blot analysis of total RNA obtained
from tissues of Mmp24/ and Mmp24/ mice revealed the
presence of a shorter Mmp24 transcript corresponding to the
expected targeted deletion in cerebellum from knock-out mice
(Fig. 1C). To support an absence of functional MT5-MMP in
Mmp24/ mice, we expressed in COS-7 cells a recombinant
protein (MT5-MMP) lacking those domains encoded by the
exons removed in Mmp24/ mice, and analyzed its ability to
activate proMMP-2, a characteristic enzymatic function of the
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MT-MMPs (22). As shown in Fig. 1D, co-transfection of COS-7
cells with full-length proMMP-2 and MT5-MMP expression
plasmids resulted in proMMP-2 activation, as assessed by the
generation of the 62-kDa band corresponding to active MMP-2.
Similar results were obtained when COS-7 cells were transfected
with an expression vector for MT1-MMP, whose ability to
activate proMMP-2 is well-established (22). In contrast, co-
transfection of the same cells with proMMP-2 and MT5-MMP
expression vectors failed to demonstrate active MMP-2 (Fig.
1D). Taken together, these results indicate that in the unlikely
event that Mmp24/mice produce a small amount of truncated
MT5-MMP, this mutant protein should be devoid of enzymatic
activity. Physiological characterization delineated that mutant
mice were viable, developed normally, and showed no overt
abnormalities. Further, males and females were fertile and their
long-term survival rates were indistinguishable from those of
their wild-type littermates.
Altered Nociceptive Thermal Response in Mmp24/ Mice Is Charac-
terized by Enhanced Sensitivity to Noxious Heat. According to the
Mmp24 expression pattern in neural tissues together with the
absence of mechanical allodynia from neurophatic origin in
another strain of Mmp24/mice (21), we performed a detailed
analysis of sensory nociceptive responsiveness inMmp24-mutant
mice. As can be seen in Fig. 2 A and B, nociceptive tests
determined that Mmp24/ mice exhibit an increased response
to thermal noxious stimuli. Thus, in the unilateral hot plate test
(set at 52.00  0.50 °C), wild-type mice exhibited thermal
withdrawal latencies of about 14 s while these values were
significantly lower in Mmp24-deficient mice (Fig. 2A). Further-
more, the mean temperature at which 50% of wild-type mice
withdrew their paws from the hot plate was 51.20  0.35 °C
whereas in Mmp24-deficient mice this value was significantly
lower (46.60  0.52 °C, P  0.01) (Fig. 2B). Further, no
differences were observed in the mechanical nociceptive tests
betweenMmp24/ andMmp24/mice (Fig. S1). These results
indicate the involvement of MT5-MMP in the detection of acute
thermal noxious stimuli.
Hypertrophy of Nociceptive Cutaneous Innervation in Mmp24/
Mice.Neurons involved in pain perception are located in sensory
ganglia and can be divided into NGF-dependent trkA pepti-
dergic and GDNF-dependent c-ret non-peptidergic subtypes,
selectively recognized with antibodies to CGRP/SP and the
lectin IB4, respectively (1, 23). We demonstrated by immuno-
fluorescence that neurons in adult DRGs express MT5-MMP
(Fig. 3A). Furthermore, double staining with antibodies to
CGRP or the IB4 lectin revealed that all MT5-MMP-positive
cells are peptidergic sensory neurons, whereas non-peptidergic
neurons do not exhibit detectable levels of this metal-
loproteinase. This suggests that effects of the Mmp24-deficiency
would likely be restricted to NGF-dependent nociceptive neu-
rons (Fig. 3 B and C). Immunohistochemical analyses of skin
innervation in adult mice footpads with antibodies to the general
neuronal marker PGP9.5 and the specific peptidergic C-fiber
marker CGRP, identified a significant increase in the density of
PGP9.5 and peptidergic fine nerve endings in Mmp24 mutants
compared to wild-type littermates (Fig. 3 D–F). Moreover, close
inspection of the epidermis of Mmp24-deficient mice indicated
that single PGP9.5 fine nerve fibers were not only more
numerous but more ramified, with secondary branches which
often traveled parallel to the skin surface for relatively long
distances, a feature never observed in the wild-type skin (Fig.
S2). As the number of sensory neurons remained unaltered by
Fig. 1. Gene targeted disruption of the MT5-MMP gene. (A) Restriction maps of the MT5-MMP (Mmp24) gene region of interest (top) and the targeting
construct (bottom). B, BamHI; RV, EcoRV; X, XhoI; X with superimposed X, destroyed XhoI. (B) Southern blot analysis of Mmp24/, Mmp24/, and Mmp24/
mice. (C) Detection of Mmp24 mRNA in cerebellum by Northern blot analysis. Liver tissue was loaded as a negative control. (D) Analysis of proMMP-2 activation
by transient transfections of the full-length Mmp24 wild-type cDNA and the MT5-MMP truncated form, obtained from cerebellum of knock-out mouse. The
asterisk indicates an unspecific gelatinolytic activity present in the conditioned medium of untransfected COS-7 cells. C, conditioned medium, used as a control,
from the human fibrosarcoma HT1080 cell line that endogenously produces both pro-MMP-2 and pro-MMP-9.
Fig. 2. Enhanced sensitivity to noxious thermal stimuli in Mmp24-deficient
mice. (A) Thermal nociceptive responses of Mmp24/ (n 10; black bars) and
Mmp24/ (n  9; white bars) mice were assessed by using the unilateral hot
plate (UHP) test set at 52.0 0.5 °C (**, P 0.01). (B) Percentage of Mmp24/
(n  6; black circles) and Mmp24/ (n  5; open circles) mice which respond
to a different set of temperatures in 1 min (F6,94  795,09; **, P  0.01).
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the mutation, these results collectively indicate that peptidergic
sensory C-fibers in the skin of Mmp24/ mice are more highly
branched, suggesting that MT5-MMP is essential for determin-
ing the size of the receptive field of cutaneous nociceptive
neurons. To further determine whether the cutaneous hyperin-
nervation phenotype of Mmp24/ mice could be the result of
enhanced neuritic outgrowth of their nociceptive neurons, we
cultured neonatal DRG neurons in the presence of 10 ng/mL
NGF. NGF-dependent neurons from Mmp24/ neonatal mice
exhibited increases in neurite ramifications and varicosities
compared to neurons fromMmp24/mice (Fig. 3G andH).We
quantitated neurite growth in neurons seeded on collagen and
observed significant increases in the number of branch points
and in the total number of secondary neurites per neuron in
Mmp24/ cultures in comparison to the wild-type ones (Fig.
S3A). Further, the same branching phenotype was demonstrated
by neurons labeled with anti-CGRP (Fig. S3B), but not by those
labeled with the IB4 lectin (Fig. S3C), suggesting that the
CGRP fiber hypertrophy observed in mutant skin results from
a more profuse branching activity by sensory neurons.
Absence of Thermal Inflammatory Hyperalgesia in Mmp24/Mice. It
has long been appreciated that peptidergic CGRP neurons
contribute to the enhanced pain responsiveness that follows
target tissue injury, as is the case for inflammation (1). Consid-
ering the cutaneous hyperinnervation phenotype observed in
Mmp24/ mice, we further analyzed how this increase in the
sensory fibers might affect the hyperalgesic responses under
inflammatory conditions. Peripheral inflammation was induced
in Mmp24/ and Mmp24/ mice by carrageenan intraplantar
injection and thermal withdrawal latencies were measured. As
the thermal latencies obtained in basal conditions were lower in
Mmp24/ mice compared to wild-type animals, the hot plate
temperature was adjusted in each case to yield basal values
(non-inflamed) of 14 s. The magnitude of the inflammation, as
determined by the volume of the paw injected with carrageenan
(right), was similar in both wild-type and Mmp24/ mice (Fig.
S4A). In agreement, histological examination of the inflamed
paws showed no overt differences (Fig. S4B). We next analyzed
the hyperalgesic response to thermal stimulation. As expected,
wild-type mice exhibited lower withdrawal latencies in the
inflamed (right) paws compared to the corresponding non-
inflamed (left) paws when measured after carrageenan admin-
istration. However, inflamed and non-inflamed hindpaws of
Mmp24-deficient mice showed similar withdrawal latencies at
the different times studied (Fig. 4). The unanticipated dimin-
ishment of hyperalgesia development in Mmp24/ mice fol-
lowing inflammatory injury, led us to evaluate the effect of
factors released during the inflammatory process. As shown in
Fig. S5 A–E, the withdrawal latencies obtained in the hind paws
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Fig. 3. MT5-MMP expression and hyperinnervation of the skin in footpads of
wild-type and Mmp24-deficient mice. (A–C) Sections through lumbar DRGs im-
munostained for MT5-MMP (red) alone (A) or in combination with antibodies to
CGRP (B) or with the IB4 lectin (C) (green). Notice that MT5-MMP neurons are
CGRPbut not IB4. (DandE) Confocal micrographs showing the innervation of
the epidermis and upper dermis at comparable locations in the footpads of
Mmp24/ and Mmp24/ adult mice as shown by double immunofluorescence
with anti-CGRP (green) and anti-PGP9.5 (red). The structure of the tissue is
revealedbythefluorescenthistochemicalDNAmarkerTOPRO(blue). Thebroken
lines indicate the limit between upper dermis (d) and epidermis (e) and the skin
surface. Arrowheads indicate examples of fine nerve endings in the epidermis
that are only labeled with anti-PGP9.5 antibodies. Arrows point at fine nerve
endings that are also labeled with anti-CGRP antibodies. (F) Quantification of the
innervation to the epidermis in footpads of Mmp24/ and Mmp24/ mice.
Because mutant and wild-type skins do not differ in epidermal thickness, the
quantitative analyses were carried out on three grids of fixed width per section
onfour sectionsperanimalandthemeanofeachparameterwasobtained.Mean
numbers of fine nerve endings (FNE)/mm SEM of three mice of each genotype
are shown. The parameters analyzed were the number of PGP9.5 and CGRP
FNE. (G and H) Isolated neonatal DRG neurons from Mmp24/ and Mmp24/
mice plated on collagen and cultured for 2 days in the presence of 10 ng/mL NGF,
fixedandimmunostainedwithantibodies toneuronal tubulin. (Scalebars inA, 50
m; B and C, 25 m; D and E, 40 m; G and H, 25 m.)
Fig. 4. Altered hyperalgesic behavior in Mmp24-deficient mice after in-
traplantar injection of carrageenan. Carrageenan-induced inflammatory
thermal hypernociception in wild-type (n 5) and Mmp24-deficient mice (n
5, **, P  0.01). Right, right paw (injected); Left, left paw (sham).
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of wild-type mice receiving intraplantar injection of TNF- (30
pg/25 L), IL-1 (30 pg/25 L), IL-6 (30 pg/25 L), NGF (1
g/25 L), or PGE2 (100 ng/25 L) were significantly lower (P
0.05) than those obtained in the non-injected contralateral paw.
However, only the administration of IL-6 and PGE2 produced
hyperalgesia in Mmp24/ mice, whereas TNF-, IL-1, and
NGF had no effect, suggesting that these proteins act through an
inflammatory pathway which is altered in knock-out mice.
Abnormal Interactions between Mmp24/ Mast Cells and Sensory
Neurons. The absence of an inflammatory response to TNF-,
IL-1, or NGF in Mmp24/ mice, prompted us to analyze the
cellular mechanisms involved in peripheral sensitization during
inflammation.AlthoughNGFcandirectly sensitize nociceptors, the
NGF-induced hyperalgesic effect can be reduced by preventing
mast cells degranulation, suggesting that mast cells are required to
enable NGF to have its full effect on nociceptive terminals (24, 25).
Accordingly, we analyzed the dynamics and characteristics of mast
cells present in skin samples fromMmp24/ andMmp24/ adult
mice. Electron microscopy analysis demonstrated a significant
increase in the number of degranulated mast cells in mutant skin
when compared to wild-type samples (61.5 3.1% vs. 41.2 2.0%,
respectively, n  3 animals per genotype, P  0.01; Fig. S6 A and
B). Degranulation of mast cells can be experimentally induced by
topical application of capsaicin to mesentery preparations (26), as
such, we used this approach to functionally evaluate mast cell
degranulation in Mmp24/ mice in vivo. First, under basal con-
ditions we observed the same phenotype as that detected in the
mutant skin. Although a similar number of mast cells were present
in Mmp24/ and Mmp24/ mice, the percentage of mast cells
which were degranulated was significantly higher in samples from
mutant mice than in wild-type samples (62.1  4.0% vs. 17.4 
0.7%, respectively, n  3 animals per genotype, P  0.001; Fig. S6
C and D). Furthermore, wild-type mast cells responded to exoge-
nous administration of capsaicin as the percentage of degranulated
mast cells increased around 50% (27.2  2.6%, n  3, P  0.05)
following the treatment, in agreement with previous data (26).
Significantly, we did not observe any increases in the mutant
samples (52.5  1.7%, n  3, P  0.07), suggesting that abnormal
mast cell degranulation in Mmp24/mice may prevent the action
of exogenous inflammatory stimuli.
To study potential interactions between mast cells and neurons,
as well as to analyze the effects of theMmp24mutation on themast
cells directly, we obtained primary cultures of bonemarrow-derived
mast cells (BMMCs) from wild-type and mutant mice. In cultures
of isolated BMMCs, we observed that the percentage of degranu-
lated cells was similar inwild-type (16.3 2.5%, n 3 cultures from
independent animals per genotype) and mutant cultures (19.5 
3.5%, n 2), an indication that lack ofMT5-MMPdoes not directly
affect mast cell basal degranulation. Therefore, to analyze if the
degranulating phenotype observed in mutant mice was due to
abnormal interactions between mast cells and sensory neurons, we
performed co-culture experiments between mast cells and sensory
neurons. In co-cultures of wild-type BMMCs and wild-type neu-
rons, immune cells appeared to extend cellular processes which
approached sensory fibers, although they maintained spatial dis-
tance from the mast cells. However, in co-cultures of mutant
neurons and BMMCs, fibers were always closely apposed to mast
cells (Fig. S6E). To evaluate whether these morphological changes
were functionally relevant, we studied BMMC degranulation in the
different co-culture conditions. In co-cultures of wild-type neurons
and wild-type BMMCs the percentage of degranulated mast cells
was very low (Table S1) and virtually identical to that found in
wild-type or mutant BMMC-only cultures (see above). Treatment
with capsaicin or NGF resulted in the degranulation of themajority
of mast cells present in the wild-type/wild-type cultures. Remark-
ably, in co-cultures of mutant neurons with mutant BMMCs the
percentage of degranulated BMMCs was over 70% under basal
conditions (Table S1), and could not be increased with the subse-
quent capsaicin or NGF treatment. These results indicate that the
lack of hyperalgesic responses in vivo after inflammation may be
due to the inability of mast cells to release mediators required for
fiber sensitization. Consequently, to determine whether the abnor-
mal degranulating phenotype was due to altered physical contact
between mutant neurons and mutant mast cells, we indirectly
co-cultured mutant DRG sensory neurons and mutant BMMCs
using transwell insets. Under these conditions, we did not observe
abnormal degranulation of mast cells in mutant/mutant co-cultures
(70 degranulated cells out of 182 total cells in wild-type neuron/
wild-type BMMC co-cultures; 79 out of 177 cells in mutant neuron/
mutant BMMC co-cultures; 70 out of 171 in mutant neuron/wild-
type BMMC co-cultures; and 80 out of 198 in wild-type neuron/
mutant BMMC co-cultures), an indication that the altered physical
contact betweenmutant neural and immune elements underlies the
mast cell ectopic release response. These results indicate that
cellular interactions between mast cells and sensory fibers are
altered in the absence of MT5-MMP and result in an abnormal
physiological response.
Changes in N-Cadherin Underlie Effects of MT5-MMP in Mast Cell-
Neuron Interactions.To gain an insight into themechanism bywhich
MT5-MMP regulates the interaction between immune and neural
cells, and hence inflammatory pain, we studied the potential actions
of this metalloproteinase in the regulation of cell adhesion. Inter-
estingly, N-cadherin plays a role in the stabilization of neurite
branches, is expressed by mast cells and its trafficking to sites of
interaction with the neurites appears to be induced by neurites,
suggesting its implication in the establishment of neuro-immune
synapses (27, 28). Our experiments revealed that mutant neurons
exhibited increased accumulation of N-cadherin labeling than wild-
type neurons (Fig. 5 A and C). Although this result could be the
consequence of mutant neurons having more branching points,
western blot analysis of homogenates from sensory neuron cultures
of both genotypes indicated that the absence of functional MT5-
MMP significantly reduces the level of cleaved intracellular C-
terminal fragments of N-cadherin. This suggests that mutant neu-
rons have higher levels of full length N-cadherin at the membrane
(Fig. S7). In agreement with the observed changes in N-cadherin
processing, levels of -catenin in the mutant neurons were signif-
icantly increased relative to wild-type neurons (Fig. 5 B and D and
Fig. S7). MT5-MMP mast cells also expressed N-cadherin. Both
molecules exhibited similar distributions in both neurons and
BMMCs (Fig. 5 E–G). Interestingly, we could observe that at
contact sites between neurites and BMMCs, the labeling for
N-cadherin and MT5-MMP became more homogeneous and in-
tense (Fig. 5G). As in neurons, the lack of MT5-MMP in BMMCs
also resulted in an abnormal processing of N-cadherin and in
increased levels of -catenin, as assessed by western blot analysis
(Fig. S7).
To test whether N-cadherin and MT5-MMP play a role in the
functional interaction between neurons and mast cells, we treated
co-cultures of neurons and mast cells of different genotypes with
anti-N-cadherin function blocking antibodies or with control IgGs,
and analyzed the BMMC degranulating phenotype by cresyl violet
staining. In agreement with previous experiments showing that
degranulation requires direct contact between neural and immune
cells (27), our results indicated that normal degranulation requires
N-cadherin-mediated cell-cell interaction between mast cells and
neurites, as no degranulation could be elicited by capsaicin in
anti-N-cadherin antibody-treated wild-type/wild-type co-cultures
(Table S2). Interestingly, addition of N-cadherin antibodies, but not
of the control IgGs, rescued the abnormal degranulating phenotype
observed in mutant/mutant co-cultures (Table S2). Thus, N-
cadherin modulates neuro-immune synapses and regulation of this
cell-adhesion molecule byMT5-MMP appears essential for inflam-
matory pain responses.
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Discussion
We show herein that MT5-MMP plays an important role in
cell-cell interactions between nociceptive neurites andmast cells.
Our data demonstrates that the absence of MT5-MMP leads to
a phenotype of hyperinnervation and enhanced sensitivity to
noxious thermal stimuli in Mmp24/ mice. The absence of
MT5-MMP in nociceptive peptidergic sensory neurons alters
fiber outgrowth in a cell autonomous way. As each mutant
sensory neuron supplies larger cutaneous territories, it is likely
that a high number of these neurons will be recruited by the
noxious thermal stimulation, increasing the final sensory inflow
that reaches second-order neurons at the central nervous system.
We have found that virtually all MT5-MMP expressing neurons
in DRGs are CGRP and that, conversely, MT5-MMP is not
expressed by IB4 neurons. It is generally accepted that the
peptidergic population is involved in the enhanced pain respon-
siveness that follows inflammatory processes (1). In agreement with
MT5-MMP expression in peptidergic neurons, our behavioral
analysis of Mmp24/mice has shown that MT5-MMP is essential
for the development of inflammatory hyperalgesia. However, the
finding of diminished thermal pain responsiveness after carra-
geenan injection resulted rather surprising in light of our previous
observation that CGRP fibers hyperinnervate the skin in mutant
animals. A detailed analysis of the effect of different factors
released during the inflammatory process (29, 30) revealed that
only the administration of IL-6 and PGE2 produced hyperalgesia in
Mmp24/ mice, whereas TNF-, IL-1, and NGF had no effect,
suggesting that these proteins act through an inflammatory pathway
which is altered in the mutant mice. As the action of these factors
during the inflammatory process can be organized into an ampli-
fication cascade, whereby NGF would be the last protein effector
(31), we focused on the evaluation of the hyperalgesia induced by
NGF in the inflammatory setting. Although NGF can directly
sensitize nociceptors, pharmacological approaches have indicated
that mast cells are necessary mediators in the hyperalgesic pheno-
type through the release of several neuroactive molecules in re-
sponse to NGF stimulation (24, 32–34). We have observed an
abnormal increase in degranulatedmast cells inMmp24/ samples
under basal conditions. Furthermore, the increase precluded the
degranulation-inducing effect of either capsaicin or NGF and
correlated with a lack of hyperalgesia after NGF administration in
vivo. Therefore, our results are consistent with previous reports
describing that mast cell degranulation is a necessary intermediate
in inflammatory hyperalgesia.
Our results also indicate that mast cell degranulation requires
physical cell-cell interaction with sensory neurites, and that MT5-
MMP regulates this interaction by a mechanism involving N-
cadherin, the expression of which has been reported to be concen-
trated at the sites of contact mediating nerve-mast cell synaptic
interaction (27). In addition, it has been previously shown that
MT5-MMP activity generates a C-terminal fragment from N-
cadherin cleavage in heterologous cells (20). Consistently, we have
shown that N-cadherin is a substrate of MT5-MMP in vivo.
Moreover, the finding that the blockade of N-cadherin rescues the
abnormal interactions between Mmp24/ mast cells and neurons
supports the hypothesis that the Mmp24/ phenotype is a conse-
quence of altered N-cadherin activity in both cell types. Changes in
cell adhesion are likely mediators of the hyperinnervating pheno-
type. Neuritogenesis is a highly dynamic process involving constant
extensions and retractions. N-cadherin participates in this process
by stabilizing neurite branches (28). It has been demonstrated that
overexpression of N-cadherin and -catenin in hippocampal neu-
rons enhances their dendritic arborization (35). Consequently, we
have observed that Mmp24 mutant DRG sensory neurons display
high levels of -catenin. Therefore, changes in N-cadherin
processing and distribution, as well as the higher levels of
-catenin observed in Mmp24/ DRG cultures and BMMCs,
may underlie both the neuritic growth and the nerve-mast cell
interaction phenotypes.
In conclusion, our results provide causal evidence that the
absence of a MMP family member, specifically MT5-MMP,
causes a cutaneous phenotype of hyperinnervation and a mor-
phological and functional alteration in neuro-immune interac-
tions. Further, we demonstrate that these changes have complex
consequences on nociceptive thermal responses, under physio-
logical and pathological conditions. Many reports have evi-
denced the importance of the MMP family of proteolytic en-
zymes in the pathology of the peripheral and central nervous
system. The increased expression and detrimental contribution
of these enzymes to a number of pathologies such as blood–brain
barrier dysfunction, demyelination, neuroinflammation, spinal
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Fig. 5. Increased N-cadherin levels in the absence of MT5-MMP. (A and C) Isolated DRG neurons from Mmp24/ (A) and Mmp24/ (C) mice plated on collagen
and cultured for 2 days in the presence of 10 ng/mL NGF, fixed and co-immunostained with antibodies to neuronal tubulin (red) and N-cadherin (green). Insets
show a stretch of a labeled neurite at higher magnification. (B and D) Isolated neonatal DRG neurons from Mmp24/ (B) and Mmp24/ (D) mice plated on
collagen and cultured for 2 days in the presence of 10 ng/mL NGF, fixed and co-immunostained with antibodies to N-cadherin (green) and to -catenin (red).
Insets show a stretch of a labeled neurite at a higher magnification showing co-localization at varicosities. (E) Co-culture of wild-type BMMCs and DRG neurons
labeled with antibodies to MT5-MMP (red) and to N-cadherin (green). (F and G) BMMCs and DRG neurons in wild-type/wild-type (F) and mutant/mutant (G)
co-cultures labeled with antibodies to neuronal tubulin (red) and to N-cadherin (green) as well as with Cy3-conjugated streptavidin (blue) which specifically labels
mast cell granules. (Scale bars in A–D, 20 m; E–G, 15 m.)
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cord injury, multiple sclerosis, and haemorrhagic stroke has
suggested the use of metalloproteinase inhibitors for the treat-
ment of neurological diseases (7, 36, 37). Beyond these previous
proposals, and based on the results presented herein, we con-
clude that some metalloproteinases may also constitute relevant
targets for pain control (3).
Materials and Methods
Refer to SI Material and Methods for detailed histological and immunocyto-
chemical methods and for a description of the knock-out construct and mouse
characterization.
Generation ofMmp24-Deficient Mice. For detailed methods refer to SIMaterial
andMethods. Briefly, a PGK-neo cassette with the transcriptional orientation
opposite to that of Mmp24 gene replaced a 6-kb fragment containing exons
5–7 of the gene. The heterozygous stem cells 14.1 (129/Ola derived) obtained
by homologous recombination were aggregated to CD1 morulas. Chimeric
males generated were mated with C57BL/6J females and the offspring was
screened by Southern blot analysis of tail genomic DNA. The heterozygous
littermates were mated to obtain homozygous mutant mice.
Behavioral Tests. Experimental procedures were approved by the Comite´ E´tico
de Experimentacio´n Animal, Universidad de Oviedo, Spain. For detailed meth-
ods refer to SI Material and Methods. Briefly, thermal nociceptive responses
were assessed by using the unilateral hot plate test, as described (38). Me-
chanical sensitivity was assessed using a modification of the Randall-Selitto
test (39) and von Frey filaments as described (40). For intraplantar injections,
drugs were dissolved in 25L and administered in the plantar side of the right
hindpaw.
DRG Neuron Culture. Wild-type and mutant neonatal mice were decapitated
and around 50 DRGs per animal were dissected out and collected in L15 media.
Ganglia were incubated at 37 °C with 2 mg/mL collagenase followed by 0.05%
trypsin. Approximately 2,000 neurons were plated in 1 mL defined medium
(refer to SI Material andMethods) using 24-well plates with coverslips coated
with poli-DL-ornithine (0.5 mg/mL; Sigma) plus collagen I (1.5 mg/mL; Invitro-
gen). Neurons were maintained in culture for 48 h at 37 °C in a humidified
incubator under 5% CO2. For immunolabeling experiments refer to SIMaterial
and Methods.
Nerve-Mast Cell Co-Culture. For detailed methods refer to SI Material and
Methods. Briefly, bone marrow-derived mast cells (BMMCs) were isolated
from femurs and tibias of adult wild-type and mutant mice and cultured in the
presence of 10 ng/mL recombinant mouse IL-3 (PreProtech) for 4–9 weeks at
37 °C in 5% CO2 to allow for the differentiation of differentiation of BMMCs
(41). For co-cultures, BMMCs (1  104 cell/mL) were added to 5-day-old
dissociated DRG cultures and incubated in supplemented Hams F-12 medium
including 10 ng/mL IL-3. Some BMMCs were cultured alone as controls.
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